Jason Ryan
CIK 1585017 · Executive Chairman · last filed 2025-08-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$759
Companies
6
Total Filings
64
Lifetime Open-Market Net
-$18.54M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WGSWW | Director | 135,473 | $0.01 | $759 | -$8.15M | 11 | 2025-08-27 |
| Singular Genomics Systems, Inc. (OMIC) Delisted | Director | — | $20.01 | — | $0 | 3 | 2024-05-31 |
| SomaLogic, Inc. (SLGCW) Delisted | Director | — | $0.09 | — | $0 | 1 | 2023-06-12 |
| GeneDx Holdings Corp. (SMFRW) Delisted | Executive Chairman | 263,358 | $0.02 | $6.3K | -$20.4K | 6 | 2023-01-04 |
| Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | See Remarks | — | $11.19 | — | $0 | 2 | 2020-02-12 |
| Foundation Medicine, Inc. (FMI) Delisted | Chief Financial Officer | 49,170 | — | — | -$10.37M | 38 | 2018-07-05 |
Recent Filings · Page 3 of 7
64 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-12 | GeneDx Holdings Corp. (SMFRW) Delisted | Exer (M) | +12,836 | $0 | EDGAR |
| 2022-01-20 | GeneDx Holdings Corp. (SMFRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-10-19 | GeneDx Holdings Corp. (SMFRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-12 | Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-04 | Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-08-02 | — | Mixed | −49,170 | -$6.74M | |
| 2018-07-05 | Foundation Medicine, Inc. (FMI) Delisted | Sell (S) | −3,403 | -$465.1K | EDGAR |
| 2018-04-18 | Foundation Medicine, Inc. (FMI) Delisted | Sell (S) | −3,449 | -$256.3K | EDGAR |
| 2018-04-05 | Foundation Medicine, Inc. (FMI) Delisted | Sell (S) | −1 | -$72 | EDGAR |
| 2018-04-03 | Foundation Medicine, Inc. (FMI) Delisted | Mixed | +6,793 | $550.4K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.